The PANNA network is made of 17 centres across 7 European countries and collects pharmacokinetic data in HIV-positive pregnant women. It is led by David Burger at the Radboud University Nijmegen Medical Centre in the Netherlands.
Right now the network focuses on collecting much needed pharmacokinetic data on newly developed antiretroviral drugs during pregnancy in European populations, but could also collect these data for other antiviral compounds such as those for use against hepatitis C.
Please find more about the network and various related studies here.
This study is funded by Fondazione PENTA Onlus. Additional support is provided by NEAT, Merck, BMS, Janssen and CTN.